Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
暂无分享,去创建一个
[1] K. Wheeler,et al. In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole. , 1984, British Journal of Cancer.
[2] K. Wheeler,et al. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole. , 1984, British Journal of Cancer.
[3] R. Mulcahy,et al. Enhancement of nitrosourea cytotoxicity by misonidazole in vitro: correlation with carbamoylating potential. , 1984, British Journal of Cancer.
[4] R. Meyn,et al. Variation in normal and tumor tissue sensitivity of mice to ionizing radiation-induced DNA strand breaks in vivo. , 1983, Cancer research.
[5] P. Workman,et al. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice. , 1983, British Journal of Cancer.
[6] J. Brown,et al. Role of glutathione in the hypoxic cell cytotoxicity of misonidazole. , 1983, Cancer research.
[7] A. Rauth,et al. Oxygen tension, cellular respiration, and redox state as variables influencing the cytotoxicity of the radiosensitizer misonidazole. , 1982, Radiation research.
[8] D. Siemann,et al. Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review. , 1982, International journal of radiation oncology, biology, physics.
[9] J. Brown,et al. The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles. , 1982, International journal of radiation oncology, biology, physics.
[10] T. Mcelwain,et al. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts. , 1982, American journal of clinical oncology.
[11] F. Stewart,et al. Thiol radioprotection in vivo: the critical role of tissue oxygen concentration. , 1981, The British journal of radiology.
[12] J. Biaglow. Cellular electron transfer and radical mechanisms for drug metabolism. , 1981, Radiation research.
[13] I. Tannock. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU. , 1980, British Journal of Cancer.
[14] A. Rauth,et al. An experimental and analytical study of oxygen depletion in stirred cell suspensions. , 1980, Radiation research.
[15] A. J. Varghese,et al. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. , 1980, Cancer research.
[16] A. Rauth,et al. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro. , 1980, British Journal of Cancer.
[17] H. Bohlen. Intestinal tissue PO2 and microvascular responses during glucose exposure. , 1980, The American journal of physiology.
[18] L. Brady,et al. Radiation sensitizers, their use in the clinical management of cancer , 1980 .
[19] J. Biaglow. The effect of hypoxic cell radiosensitizing drugs on cellular oxygen utilization. , 1980, Pharmacology & therapeutics.
[20] J. Hendry. Quantitation of the radiotherapeutic importance of naturally-hypoxic normal tissues from collated experiments with rodents using single doses. , 1979, International journal of radiation oncology, biology, physics.
[21] J. Brown,et al. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. , 1977, Radiation research.
[22] E. Clarke,et al. Oxygen inhibition of nitroreductase: electron transfer from nitro radical-anions to oxygen. , 1976, Biochemical and biophysical research communications.